RFG Advisory’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-773
Closed -$277K 649
2023
Q3
$277K Sell
773
-37
-5% -$14.3K 0.01% 527
2023
Q2
$307K Sell
810
-2
-0.2% -$814 0.01% 520
2023
Q1
$389K Sell
812
-11
-1% -$5.15K 0.02% 461
2022
Q4
$388K Buy
823
+99
+14% +$40K 0.02% 462
2022
Q3
$277K Buy
724
+70
+11% +$34.9K 0.02% 503
2022
Q2
$353K Sell
654
-28
-4% -$14.6K 0.02% 428
2022
Q1
$384K Buy
682
+79
+13% +$47.6K 0.02% 375
2021
Q4
$456K Sell
603
-71
-11% -$53.1K 0.03% 321
2021
Q3
$503K Sell
674
-101
-13% -$75.7K 0.04% 273
2021
Q2
$499K Sell
775
-20
-3% -$12.2K 0.04% 267
2021
Q1
$454K Sell
795
-7
-0.9% -$4.14K 0.05% 271
2020
Q4
$498K Sell
802
-64
-7% -$36.4K 0.07% 246
2020
Q3
$446K Buy
866
+68
+9% +$34.4K 0.06% 246
2020
Q2
$360K Buy
798
+136
+21% +$60K 0.06% 253
2020
Q1
$232K Buy
+662
New +$243K 0.04% 300

Other funds holding BIO